Friday, January 8, 2016

Xcovery Announces Updated Clinical Data on X-396 in Patients with ALK+ Non-Small Cell Lung Cancer at the 4th AACR-IASLC International Joint Conference

… kinase (ALK+) advanced non-small cell lung cancer (NSCLC) from an ongoing Phase … trial. About Non-Small Cell Lung Cancer and ALK Lung cancer is the second most … . Non-small cell lung cancer is the most common type of lung cancer, accounting for an estimated 85-90% of the lung cancer cases …

No comments:

Post a Comment